A detailed history of Cigna Investments Inc transactions in Biogen Inc. stock. As of the latest transaction made, Cigna Investments Inc holds 1,524 shares of BIIB stock, worth $342,305. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,524
Previous 1,544 1.3%
Holding current value
$342,305
Previous $400,000 17.75%
% of portfolio
0.06%
Previous 0.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$212.02 - $267.71 $4,240 - $5,354
-20 Reduced 1.3%
1,524 $329,000
Q4 2023

Jan 22, 2024

SELL
$222.59 - $267.94 $890 - $1,071
-4 Reduced 0.26%
1,544 $400,000
Q3 2023

Oct 23, 2023

SELL
$253.3 - $285.89 $49,393 - $55,748
-195 Reduced 11.19%
1,548 $398,000
Q2 2023

Aug 01, 2023

SELL
$275.25 - $318.06 $3,578 - $4,134
-13 Reduced 0.74%
1,743 $497,000
Q1 2023

May 11, 2023

SELL
$256.56 - $292.34 $11,032 - $12,570
-43 Reduced 2.39%
1,756 $488,000
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $252 - $306
1 Added 0.06%
1,799 $498,000
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $18,300 - $25,235
-94 Reduced 4.97%
1,798 $480,000
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $128,652 - $152,991
-686 Reduced 26.61%
1,892 $386,000
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $152,109 - $191,649
-785 Reduced 23.34%
2,578 $542,000
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $296,246 - $380,719
-1,323 Reduced 28.23%
3,363 $806,000
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $34,241 - $44,655
-121 Reduced 2.52%
4,686 $1.33 Million
Q2 2021

Aug 10, 2021

SELL
$259.0 - $414.71 $197,617 - $316,423
-763 Reduced 13.7%
4,807 $1.67 Million
Q1 2021

May 10, 2021

BUY
$242.95 - $284.63 $31,340 - $36,717
129 Added 2.37%
5,570 $1.56 Million
Q4 2020

Feb 11, 2021

BUY
$236.26 - $355.63 $38,510 - $57,967
163 Added 3.09%
5,441 $1.33 Million
Q3 2020

Nov 12, 2020

SELL
$264.77 - $305.71 $96,111 - $110,972
-363 Reduced 6.44%
5,278 $1.5 Million
Q2 2020

Aug 17, 2020

SELL
$258.66 - $342.55 $459,638 - $608,711
-1,777 Reduced 23.96%
5,641 $1.51 Million
Q1 2020

May 11, 2020

SELL
$268.85 - $341.04 $1.03 Million - $1.31 Million
-3,831 Reduced 34.06%
7,418 $2.35 Million
Q4 2019

Feb 04, 2020

SELL
$220.06 - $304.07 $145,239 - $200,686
-660 Reduced 5.54%
11,249 $3.03 Million
Q3 2019

Nov 07, 2019

BUY
$217.44 - $243.88 $55,012 - $61,701
253 Added 2.17%
11,909 $3.56 Million
Q2 2019

Aug 12, 2019

BUY
$219.29 - $241.72 $2,850 - $3,142
13 Added 0.11%
11,656 $2.77 Million
Q1 2019

May 10, 2019

BUY
$216.71 - $338.96 $703,657 - $1.1 Million
3,247 Added 38.67%
11,643 $2.75 Million
Q4 2018

Feb 06, 2019

BUY
$278.5 - $352.75 $10,861 - $13,757
39 Added 0.47%
8,396 $2.53 Million
Q3 2018

Nov 13, 2018

SELL
$293.51 - $383.83 $1.42 Million - $1.86 Million
-4,839 Reduced 36.67%
8,357 $2.54 Million
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $892,049 - $1.06 Million
3,464 Added 35.59%
13,196 $3.83 Million
Q1 2018

May 09, 2018

SELL
$260.13 - $367.91 $32,776 - $46,356
-126 Reduced 1.28%
9,732 $2.67 Million
Q4 2017

Jan 26, 2018

SELL
$307.64 - $344.58 $109,519 - $122,670
-356 Reduced 3.49%
9,858 $3.14 Million
Q3 2017

Oct 11, 2017

BUY
$281.15 - $329.69 $2.87 Million - $3.37 Million
10,214
10,214 $3.2 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.3B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Cigna Investments Inc Portfolio

Follow Cigna Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.